LIFETECH SCI (01302) announced that on November 6, 2025, the G-BranchTM Thoracoabdominal Aortic Stent Graft System (G-BranchTM or the Product), jointly developed by Professor Guo Wei's team from the First Medical Center of the Chinese PLA General Hospital and the Group, has received official registration approval from China's National Medical Products Administration (NMPA).
The Product is indicated for the treatment of thoracoabdominal aortic aneurysms (TAAA) involving the celiac trunk, superior mesenteric artery, and bilateral renal arteries, enabling complete endovascular reconstruction of TAAA. It features a globally pioneering "dual-embedded and dual-everted" hybrid branch design, with varying diameters in the upper and lower segments of the main stent. The four branches are positioned almost at the same level, aligning with the anatomical origins of human visceral branch vessels. Additionally, it allows for branch vessel reconstruction under full endovascular techniques while maintaining continuous blood supply to organs during surgery.
The Group holds independent intellectual property rights for the Product, which is expected to provide TAAA patients with a systemic solution for complete endovascular reconstruction of visceral branches. This solution is entirely interventional, offering advantages such as minimal trauma, simplified operation, and enhanced adaptability.
Following the approval and launch of the aortic arch stent system and aortic stent graft system in the first half of 2025, the approval of this Product further enriches the Group's portfolio in the peripheral vascular intervention sector. This positions LIFETECH SCI as a pioneer in delivering comprehensive endovascular aortic repair solutions globally.
As commercialization progresses, the Group will continue to provide flexible, complete, safe, effective, and user-friendly solutions for thoracoabdominal aortic aneurysm reconstruction. Collaborating with industry experts, it aims to advance the R&D and commercialization of clinically essential medical devices, driving growth in the medical equipment sector and benefiting patients worldwide.